Qiagen Nv (QIA)

Index:

Xetra DAX

  42.11
   
  • Change Today:
     0.25
  • 52 Week High:  46.04
  • 52 Week Low:  35.23
  • Currency: Euro
  • Shares Issued: 222.62m
  • Volume: 316,806
  • Market Cap:  9,373m

Qiagen Nv Overview

Qiagen is a supplier of technologies and products for preanalytical sample preparation and linked molecular assay solutions. The company’s primary customers are academic research markets, pharmaceutical and biotechnology companies, applied testing customers, and molecular diagnostic laboratories. Qiagen also provides diagnostic kits, tests, and assays for human and veterinary molecular diagnostics.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 4.9%
ROCE 5.4%
Latest F'cast
P/E 128.3
PEG n/a
Pr/Revenue 5.5
Pr/Book 3.0
Latest F'cast
Revenue 0.7%
PBT -71.8%
EPS -74.7%
DPS n/a

Qiagen Nv Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1,870.35 439.47 153.00¢ 27.7 n/a n/a n/a 0.0%
31-Dec-21 2,251.66 625.83 221.00¢ 25.7 1.1 +24% n/a 0.0%
31-Dec-22 2,141.52 512.60 186.00¢ 25.3 n/a -2% n/a 0.0%
31-Dec-23 1,965.31 429.81 150.00¢ 30.5 n/a -30% n/a 0.0%
31-Dec-24 1,978.21 121.15 38.00¢ 131.5 n/a -75% n/a 0.0%

Qiagen Nv Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 2,082.11 591.84 202.93¢ 23.9 0.1 +434% n/a 0.0%
31-Dec-26 2,199.78 642.72 218.36¢ 22.2 2.9 +8% 5.15¢ 0.0%
31-Dec-27 2,346.99 706.02 238.78¢ 20.3 2.2 +9% 11.40¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Qiagen Nv Market Data

Currency Euro
Share Price   42.11
Change Today   0.25
% Change 0.59 %
52 Week High  46.04
52 Week Low  35.23
Volume 316,806
Shares Issued 222.62m
Market Cap  9,373m

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 9
Sell 0
Strong Sell 0
Total 16
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page